Research-Grade peptide Products

A small-molecule NNMT inhibitor (technically not a peptide) grouped with peptides in fat-loss contexts, investigated in preclinical obesity and muscle-aging models.

N-acetyl-seryl-aspartyl-lysyl-proline — a naturally occurring anti-fibrotic tetrapeptide derived from the N-terminus of thymosin beta-4, regulated by ACE and studied for cardiac, renal, and pulmonary fibrosis.

A synthetic hexapeptide (Ac-Glu-Glu-Met-Gln-Arg-Arg) that modulates enkephalin signaling at the neuromuscular junction to reduce muscle contraction intensity, functioning as a complementary mechanism to Argireline for topical wrinkle reduction.

A biomimetic signaling peptide and key active ingredient in Capixyl hair loss treatments, proposed to counteract DHT-driven follicle miniaturization and reduce perifollicular inflammation.

A seven-amino-acid fragment of adrenocorticotropic hormone with cognitive-enhancing properties independent of adrenal stimulation, studied for attention, memory, and learning enhancement in both animal and human trials.

An experimental chimeric peptide that targets prohibitin on adipose vasculature, inducing apoptosis of blood vessels feeding white fat tissue. Studied in obese primates with dramatic fat reduction but no human trials to date.

A modified analog of BPC-157 incorporating alpha-aminoisobutyric acid (Aib) substitutions to enhance proteolytic stability and extend biological half-life while preserving cytoprotective activity.

A stable dipeptide form of glutamine used in clinical nutrition for gut barrier integrity, immune support, and post-surgical recovery — solving glutamine's instability problem.

A next-generation biomimetic lipopeptide from Sederma's Matrixyl family that targets age-related dermal matrix architecture changes by upregulating TGF-beta signaling, fibrillin-1, and elastic fiber network components — addressing deep structural skin aging beyond collagen alone.

A small-molecule anti-inflammatory agent repurposed for metabolic research, studied as an IKKε/TBK1 inhibitor that may reverse obesity-associated insulin resistance.

A counter-regulatory heptapeptide of the renin-angiotensin system that opposes the vasoconstrictive and pro-inflammatory effects of angiotensin II through the Mas receptor, with cardioprotective, anti-fibrotic, and anti-inflammatory properties.

A 16-amino-acid fragment of the C-terminus of human growth hormone (residues 176–191), marketed for fat-loss lipolytic activity but weak in controlled human trials.

An endogenous peptide ligand for the APJ receptor (apelin receptor) with potent cardiovascular, angiogenic, and fluid homeostasis functions, studied as a potential therapeutic in heart failure and metabolic disease.

A biotinylated derivative of the copper-binding tripeptide GHK, combining the collagen-stimulating and wound-healing properties of GHK-Cu with biotin's keratin-supporting activity for enhanced hair and nail applications.

A 15-amino-acid peptide fragment derived from gastric juice protein BPC, studied extensively in animal models for tissue healing and gut integrity.

An endogenous dipeptide (beta-alanine-L-histidine) with potent anti-glycation, antioxidant, and pH-buffering properties, concentrated in muscle and brain tissue, studied extensively for anti-aging and neuroprotective applications.

A tripeptide bioregulator (Ala-Glu-Asp) targeting cartilage and musculoskeletal tissue, studied for joint protection, cartilage regeneration, and osteoarthritis prevention in aging.

A 21-amino-acid endogenous peptide derived from chromogranin A that inhibits catecholamine release via nicotinic acetylcholine receptor antagonism, with cardiovascular protective, antimicrobial, and metabolic regulatory properties under active investigation for hypertension and heart failure.

Calcitonin gene-related peptide, the most potent endogenous vasodilator known, with a central role in migraine pathophysiology and emerging significance in wound healing and cardiovascular protection.

An investigational peptide-chrysin conjugate combining the flavonoid aromatase inhibitor chrysin with a bioactive peptide carrier to enhance bioavailability and target estrogen metabolism modulation in research contexts.

A long-acting GHRH analog featuring a Drug Affinity Complex that covalently binds serum albumin, extending the half-life to 6–8 days and producing sustained, continuous GH and IGF-1 elevation.

The most widely used GHRH + GHRP stack — CJC-1295 extends GHRH half-life while Ipamorelin selectively amplifies GH pulses without disturbing cortisol or prolactin.

A modified GHRH (1-29) analog without the Drug Affinity Complex — produces discrete, pulsatile GH release with a ~30-minute half-life, closely mimicking endogenous GH secretion patterns.

A tetrapeptide bioregulator (Ala-Glu-Asp-Gly) studied for cerebral cortex regulation, neuroprotection after ischemia, and potential cognitive benefits in aging populations.

A neuropeptide structurally related to somatostatin that promotes slow-wave sleep, modulates cortical activity, and exerts potent anti-inflammatory effects through both somatostatin-shared and cortistatin-specific receptor pathways.

A hexapeptide analog of angiotensin IV that crosses the blood-brain barrier and promotes synaptogenesis via hepatocyte growth factor (HGF) signaling — studied for cognitive enhancement and neurodegenerative disease.

A 9-amino-acid neuropeptide isolated from the rabbit brain, investigated for delta-wave sleep promotion and stress-axis modulation.

A once-weekly, cAMP-biased GLP-1 receptor agonist engineered to preferentially signal through the cAMP pathway. Investigated for type 2 diabetes and obesity, with both subcutaneous and oral formulations under development.

A once-weekly, exendin-based GLP-1 receptor agonist built on an antibody Fc fusion scaffold. Notable for the AMPLITUDE-O cardiovascular outcomes trial, which showed reductions in major cardiovascular and renal events in high-risk type 2 diabetes.

A synthetic tetrapeptide (Ala-Glu-Asp-Gly) modeled on pineal extract Epithalamin — studied by Russian researchers for telomerase, circadian, and longevity endpoints.

Alternate naming and formulation of the tetrapeptide Ala-Glu-Asp-Gly (AEDG), sometimes sold distinctly from Epitalon — same active sequence targeting telomerase activation.

A 344-amino-acid glycoprotein that antagonizes myostatin and activin A — the primary endogenous brake on skeletal muscle growth — studied for muscle wasting and gene therapy applications.

A D-retro-inverso peptide that disrupts FOXO4-p53 interactions in senescent cells, triggering selective apoptosis. The first peptide-based senolytic — published in Cell (2017) with striking mouse healthspan data.

The base copper-binding tripeptide (Gly-His-Lys) found in human plasma and tissues — a precursor to GHK-Cu with intrinsic bioactivity in wound healing, gene modulation, and anti-inflammatory signaling.

An early-generation growth-hormone-releasing peptide with potent GHSR agonism but notable prolactin elevation compared to the later selective agent Ipamorelin.

The first-generation growth-hormone-releasing peptide, notable for inducing strong hunger through ghrelin-receptor activation alongside GH release.

A long-acting GLP-2 receptor analog engineered for less-frequent dosing than teduglutide. Investigated for short bowel syndrome, it stimulates intestinal mucosal growth and absorption with a once- or twice-weekly regimen.

The master intracellular antioxidant tripeptide (gamma-L-glutamyl-L-cysteinyl-glycine) that serves as the primary cellular defense against oxidative stress, xenobiotic toxicity, and redox imbalance across virtually all human tissues.

A naturally occurring tripeptide cleaved from the N-terminus of IGF-1 in the brain, studied as a neuroprotective agent in stroke and neurodegeneration models.

A synthetic decapeptide identical to endogenous gonadotropin-releasing hormone (GnRH) — used diagnostically to assess pituitary gonadotroph reserve and therapeutically to stimulate LH/FSH release.

A synthetic analog of endogenous GnRH (gonadotropin-releasing hormone) used clinically to evaluate pituitary gonadotropin reserve and investigated for fertility and hormonal optimization protocols.

A potent GHRP with documented cardioprotective effects in ischemic animal models, distinct from other GHRPs in its non-GH receptor activity.

A modified fragment of human growth hormone (amino acids 176-191) that retains GH's lipolytic activity without its growth-promoting or diabetogenic effects. The most targeted fat-loss peptide in research use.

A 24-amino-acid mitochondrial-derived peptide (MDP) with cytoprotective, anti-apoptotic, and neuroprotective activity. Encoded within the mitochondrial genome, humanin represents a new class of retrograde signaling molecules.

An oral, non-peptide growth hormone secretagogue that mimics ghrelin at the GHSR-1a receptor — produces sustained GH and IGF-1 elevation without injections. Extensively studied in human trials.

A long-acting analog of insulin-like growth factor 1 with substitutions that reduce IGF-binding-protein affinity, extending half-life and increasing free IGF-1 activity.

The most selective GHRP (growth-hormone-releasing peptide) — amplifies GH pulses via ghrelin/GHSR receptor without meaningful cortisol, prolactin, or aldosterone crosstalk.

An exercise-induced myokine cleaved from fibronectin type III domain-containing protein 5 (FNDC5) that mediates metabolic benefits of physical activity including white-to-brown fat conversion and improved glucose homeostasis.

A copper-binding tripeptide (Lys-His-Lys) that chelates Cu2+ ions to promote collagen synthesis, wound healing, and hair follicle stimulation as an alternative to GHK-Cu.

A 10-amino-acid fragment of the endogenous kisspeptin neuropeptide that activates GnRH neurons — the master switch of the reproductive hormone axis — studied for infertility, metabolic health, and diagnostic endocrinology.

The full-length 54-amino-acid product of the KISS1 gene — the master upstream regulator of the hypothalamic GnRH pulse generator, central to puberty onset, reproductive cyclicity, and fertility.

A C-terminal tripeptide fragment of alpha-MSH with potent anti-inflammatory activity, studied for its role in modulating NF-κB signaling without melanogenic effects.

A cationic antimicrobial peptide derived from the N-terminal region of lactoferrin by pepsin digestion, possessing broad-spectrum antimicrobial, antifungal, antiviral, and immunomodulatory properties.

A tetrapeptide bioregulator (Lys-Glu-Asp-Ala) targeting liver tissue, studied for hepatoprotection, chromatin decondensation, and restoration of liver function in aging models.

A 37-amino-acid human cathelicidin antimicrobial peptide with broad-spectrum activity against bacteria, fungi, and biofilms, plus immunomodulatory and wound-healing properties.

A 43-amino-acid soy-derived peptide with epigenetic anti-cancer properties that inhibits histone acetyltransferase activity and modulates innate immunity through RGD integrin binding.

A once-weekly GLP-1 receptor and glucagon receptor (GCGR) dual agonist based on the oxyntomodulin backbone. Developed for obesity and type 2 diabetes, mazdutide couples appetite suppression with glucagon-driven energy expenditure and hepatic fat reduction.

A synthetic analog of α-MSH that binds melanocortin receptors, inducing melanogenesis (tanning) along with libido and appetite-suppression effects. Pre-PT-141 ancestor molecule.

A splice variant of IGF-1 produced locally in damaged muscle tissue, studied for its role in satellite cell activation and skeletal muscle repair.

A 16-amino-acid peptide encoded in the mitochondrial 12S rRNA — investigated as a metabolic regulator of AMPK signaling and insulin sensitivity.

An N-acetylated, amidated analog of Selank with improved metabolic stability and enhanced CNS bioavailability — studied for anxiolytic and nootropic effects.

An off-label, ultra-low-dose application of the opioid antagonist naltrexone that paradoxically upregulates endogenous endorphin and enkephalin production, widely explored for autoimmune modulation and chronic inflammation.

An 82-amino-acid anorexigenic peptide derived from nucleobindin-2 (NUCB2) that suppresses appetite through hypothalamic signaling and crosses the blood-brain barrier, studied for potential anti-obesity applications.

A synthetic MC1R antagonist peptide used in cosmetic skin-lightening formulations to inhibit melanin synthesis and transfer from melanocytes to keratinocytes, reducing hyperpigmentation.

A nine-amino-acid neuropeptide produced in the hypothalamus. The 'bonding hormone' has well-established roles in labor, lactation, and social cognition, with emerging research in autism, PTSD, and metabolic regulation.

A small peptide fragment derived from ciliary neurotrophic factor (CNTF) that promotes neurogenesis and enhances cognitive function in animal models by crossing the blood-brain barrier.

A lipidated derivative of the copper-binding tripeptide GHK, designed for enhanced skin penetration in topical anti-aging formulations.

The pentapeptide form of Matrixyl (palmitoyl pentapeptide-4) — Pal-Lys-Thr-Thr-Lys-Ser — a type I collagen fragment mimetic that is one of the most clinically validated topical peptides for wrinkle reduction and skin firmness.

A lipopeptide consisting of palmitic acid conjugated to a dipeptide sequence (Lys-Val) that stimulates collagen synthesis and extracellular matrix remodeling for anti-aging skin applications.

The original Matrixyl peptide — a lipopeptide that mimics the collagen I pro-peptide fragment to stimulate fibroblast production of collagens I, III, IV, fibronectin, and hyaluronic acid. One of the most studied anti-wrinkle cosmetic peptides.

A short synthetic peptide bioregulator (tetrapeptide) developed within the Khavinson bioregulator framework and proposed to support pancreatic tissue function. Evidence is limited and derived largely from Russian preclinical and small clinical studies.

A seven-amino-acid spadin analog that enhances BDNF signaling by blocking TREK-1 potassium channels, studied in preclinical models for antidepressant and cognitive-enhancing effects.

PEGylated Mechano Growth Factor — a splice variant of IGF-1 modified with polyethylene glycol for extended half-life. Studied for its role in muscle satellite cell activation and tissue repair.

A polyethylene glycol-conjugated variant of BPC-157 engineered for extended half-life and reduced injection frequency while retaining the parent peptide's tissue-healing properties.

A polyethylene glycol-conjugated form of thymosin alpha-1 designed to extend circulating half-life from hours to days, reducing injection frequency while preserving immunomodulatory potency.

A tripeptide bioregulator (Glu-Asp-Arg) developed by the Khavinson Institute, studied for neuroprotective and cognitive-enhancing properties through epigenetic regulation of brain tissue.

A synthetic heptapeptide analog of tuftsin, developed at the Russian Institute of Molecular Genetics as an anxiolytic nootropic administered intranasally.

A synthetic heptapeptide fragment of ACTH (4-10) developed in Russia as a cognitive enhancer, used clinically there for stroke recovery and anxiety.

The first synthetic GHRH analog approved for clinical use — GHRH (1-29) NH₂, the minimum active sequence. Shorter-acting than tesamorelin or CJC-1295.

A heptapeptide cosmetic neuropeptide that inhibits SNARE complex formation at the neuromuscular junction to reduce facial muscle contractions and dynamic wrinkles, functioning as a topical botulinum toxin alternative.

A synthetic octapeptide that mimics the N-terminal of SNAP-25, reducing neuromuscular signaling to facial muscles. The 'topical Botox' of peptide skincare — with more modest results.

A cell-permeable tetrapeptide that targets the inner mitochondrial membrane, stabilizing cardiolipin and improving electron transport chain efficiency — in late-stage clinical trials for mitochondrial and cardiac diseases.

A polypeptide complex extracted from calf thymus, used clinically in Russia for immune restoration and studied for anti-aging effects including mortality reduction in elderly cohorts.

A cell-permeable autophagy-inducing peptide derived from a key region of the Beclin 1 protein fused to the HIV-1 Tat transduction domain, engineered to potently activate cellular self-cleaning pathways.

Synthetic fragment of Thymosin β4 investigated for actin-binding, cell migration, and tissue repair across muscle, cornea, and cardiac models.

A triple monoamine reuptake inhibitor (serotonin, norepinephrine, dopamine) originally developed for neurodegenerative diseases, repurposed for obesity after demonstrating significant weight loss in clinical trials.

A thymic peptide bioregulator developed by the St. Petersburg Institute of Bioregulation and Gerontology, studied in Russian clinical cohorts for immune reconstitution and longevity.

A synthetic pentapeptide (Arg-Lys-Asp-Val-Tyr) corresponding to residues 32-36 of thymopoietin, used clinically in some countries for immune modulation in immunodeficiency and autoimmune conditions.

A synthetic pentapeptide (Arg-Lys-Asp-Val-Tyr) representing the active site of the 49-amino-acid thymic hormone thymopoietin, used clinically in several countries for T-cell immunomodulation in immunodeficiency, autoimmune conditions, and as adjunct cancer therapy.

A lesser-studied member of the beta-thymosin family with documented angiogenic and tumor-associated properties, investigated as both a cancer biomarker and a potential modulator of vascular growth.

A 43-amino acid peptide and the primary intracellular G-actin sequestering protein. TB-500 is a synthetic fragment of Thymosin Beta-4's active site — this is the full-length parent molecule with broader tissue repair and anti-inflammatory evidence.

The biologically active zinc-bound form of thymulin (facteur thymique serique), a nonapeptide secreted by thymic epithelial cells that requires zinc chelation for immunomodulatory activity.

A zinc-dependent nonapeptide hormone naturally secreted by thymic epithelial cells, studied for its role in T-cell maturation and immune system regulation.

A tripeptide bioregulator (Lys-Glu-Asp) targeting vascular endothelium, studied for cardiovascular protection, endothelial function restoration, and atherosclerosis prevention in aging.

A dipeptide bioregulator (Lys-Glu) derived from thymus tissue, studied for immune system regulation, thymic regeneration, and anti-aging effects in elderly populations.

A 28-amino-acid neuropeptide with broad immunomodulatory, vasodilatory, and neuroprotective activity. Studied in CIRS (chronic inflammatory response syndrome), pulmonary hypertension, and gut motility disorders.